Evidence map›Paper›PMID 36698842›Full record

ArticleFrontiers in medicine2022

Acute and chronic HBV infection in central Argentina: High frequency of sub-genotype F1b, low detection of clinically relevant mutations and first evidence of HDV.

Gonzalo M Castro, María J Sosa, Paola E Sicilia, María I Riberi, Claudia Moreno, Rodolfo Cattaneo, José D Debes, María G Barbás, Analía E Cudolá, María B Pisano and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Gonzalo M CastroDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
María J SosaDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
Paola E SiciliaDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
María I RiberiLaboratorio de Virología, Servicio de Microbiología, Clínica Universitaria Reina Fabiola, Universidad Católica de Córdoba, Córdoba, Argentina.
Claudia MorenoDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
Rodolfo CattaneoServicio de Gastroenterología, Hospital Rawson, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
José D DebesDepartment of Medicine, University of Minnesota, Minneapolis, MN, United States.
María G BarbásDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
Analía E CudoláDepartamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
María B PisanoLaboratorio de Hepatitis Virales, Instituto de Virología "Dr. J. M. Vanella" (InViV)-CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba (UNC), Córdoba, Argentina.
Viviana E RéLaboratorio de Hepatitis Virales, Instituto de Virología "Dr. J. M. Vanella" (InViV)-CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba (UNC), Córdoba, Argentina.
Ministerio de Salud · ARUniversidad Nacional de Córdoba · ARUniversidad Católica de Córdoba · ARUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Genomic analysis of hepatitis B virus (HBV) identifies phylogenetic variants, which may lead to distinct biological and clinical behaviors. The satellite hepatitis D virus (HDV) may also influence clinical outcomes in patients with hepatitis B. The aim of this study was to investigate HBV genetic variants, including clinically relevant mutations, and HDV infection in acute and chronic hepatitis B patients in central Argentina. Methods: A total of 217 adult HBV infected patients [acute (AHB): Results: Overall, genotype (gt) F [sub-genotype (sgt) F1b] was the most frequently found. In AHB patients, the gts/sgts found were: F1b (74.7%) > A2 (13.9%) > F4 (7.6%) > C (2.5%) > A1 (1.3%). Among CHB patients: F1b (39.1%) > A2 (23.9%) > F4 (18.2%) > D (9.4%) > C and F6 (3.6% each) > A1, A3 and B2 (0.7% each). The distribution of sgt A2 and gt D was significantly different between HBV mono and HBV/HIV coinfected patients [A2: 15.9% vs. 35.7% ( Discussion: We detected an increase in the circulation of genotype F in Central Argentina, particularly among AHB patients, suggesting transmission advantages over the other genotypes. A low rate of mutations was detected, especially those with antiviral resistance implications, which is an encouraging result. The evidence of HDV circulation in our region, reported for the first time, alerts the health system for its search and diagnosis.

Indexed as

antiviral resistanceArgentinagenotypesHBVhepatitis B virusmutant

Identifiers

PMID36698842
PMCPMC9868314
OpenAlexW4313826110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.